Form 4: Guardant Health CFO Michael Brian Bell Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Michael Brian Bell, CFO of Guardant Health, reports the vesting of performance-based restricted stock units and subsequent tax withholding.

Summary

  • On March 1, 2025, Michael Brian Bell, the CFO of Guardant Health, Inc., reported transactions involving the company's stock.
  • Bell acquired 7,108 shares of common stock through the vesting of performance-based restricted stock units (RSUs) at a price of $0.
  • Simultaneously, 2,537 shares were disposed of to cover tax withholding obligations at a price of $42.55 per share.
  • Following these transactions, Bell directly owns 37,748 shares of Guardant Health common stock and 14,220 performance-based restricted stock units.
  • The performance-based restricted stock unit award was granted on February 26, 2024, with 33% of the shares vesting on March 1, 2025, and the remaining shares vesting over the next two years.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine executive compensation transactions. The vesting of RSUs suggests performance goals were met, which is mildly positive.

Positives

  • The vesting of performance-based restricted stock units suggests that performance metrics were achieved.

Future Outlook

The remaining 67% of the performance-based restricted stock units will vest over the following two years, with 33% vesting on January 1, 2026, and 34% vesting on January 1, 2027.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.

Comparison to Industry Standards

  • Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
  • Vesting schedules for RSUs are typically structured to incentivize long-term performance and retention.
  • Tax withholding practices related to stock vesting are standard across publicly traded companies.

Stakeholder Impact

  • The vesting of RSUs aligns management's interests with shareholders by incentivizing performance.

Key Dates

DateDescription
02/26/2024Date of grant for performance-based restricted stock unit award
03/01/2025Date of transaction: vesting of RSUs and tax withholding
03/04/2025Date of Form 4 filing
01/01/2026Next vesting date for 33% of the remaining shares subject to the performance-based restricted stock unit award
01/01/2027Final vesting date for 34% of the remaining shares subject to the performance-based restricted stock unit award

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.